61
Mutzbauer Till S: (De) Transdermal applizierbares beruhigungs- und sedierungsmittel, (En) Transdermally administerable tranquilizing and sedating agent. Mutzbauer Till S, MUTZBAUER Helmut, October 28, 2004: WO/2004/091589 (1 worldwide citation)

(EN) An externally administerable agent, particularly a transdermal system for treating states of agitation or for use in preoperative sedation, contains, in an adhesive dressing preparation, a pharmaceutically effective amount of propofol (2,6-diisopropyl phenol) or of benzodiazepine or of another ...


62
Levin Galit, Sacks Hagit: Transdermal system for sustained delivery of polypeptides. Transpharma Medical, Levin Galit, Sacks Hagit, WEBB Cynthia, June 23, 2005: WO/2005/056075 (1 worldwide citation)

The present invention relates to a transdermal system for sustained delivery of high molecular weight hydrophilic drugs, especially peptide-, polypeptide- or protein-drugs and to methods of use thereof. The system comprises an apparatus that generates micro-channels in the skin of a subject in conju ...


63
Tamada Janet: Device and method for sampling of substances using alternating polarity. Cygnus, sSHAY James R, January 4, 1996: WO/1996/000109 (1 worldwide citation)

A method for sampling of a substance from a subject is provided, which comprises placing one or more sampling chambers on a collection site on a tissue surface on the subject; conducting electric current through the tissue to extract a substance from the subject in a first direction in one or more s ...


64
Effenhauser Carlo Stefan, Manz Andreas: (De) Transdermales system, (En) Transdermal system. Novartis, Effenhauser Carlo Stefan, Manz Andreas, NOVARTIS, June 13, 1996: WO/1996/017648 (1 worldwide citation)

(EN) A transdermal system (1) for delivering a substance through the skin (2) has a reservoir (11) which stores the substance for delivery and a transfer device which in operation is connected to both the reservoir and the skin by means of passage openings. This transfer device comprises a sheet sub ...


65
Parminder Singh, Eun Soo Lee, Amit K Jain: Transdermal administration of tamsulosin. Corium International, Judy M Mohr, McDermott Will & Emery, April 4, 2017: US09610253

In an aspect of the invention, a composition for making a patch for the transdermal delivery of tamsulosin is provided. The composition comprises (a) at least about 1 wt % tamsulosin or a pharmaceutically acceptable salt of tamsulosin, (b) at least about 40 wt % polyisobutylene adhesive or hydrophob ...


66
Curtis Wright, Benjamin Oshlack, Christopher Breder: Pharmaceutical formulation containing gelling agent. Purdue Pharma, The P F Laboratories, Purdue Pharmaceuticals, Lowenstein Sandler, July 4, 2017: US09693961

Disclosed in certain embodiments is a controlled release oral dosage form comprising a therapeutically effective amount of a drug susceptible to abuse together with one or more pharmaceutically acceptable excipients; the dosage form further including a gelling agent in an effective amount to impart ...


67
Curtis Wright, Benjamin Oshlack, Christopher Breder: Pharmaceutical formulation containing gelling agent. Purdue Pharma, The P F Laboratories, Purdue Pharmaceuticals, Lowenstein Sandler, January 30, 2018: US09877924

Disclosed in certain embodiments is a controlled release oral dosage form comprising a therapeutically effective amount of a drug susceptible to abuse together with one or more pharmaceutically acceptable excipients; the dosage form further including a gelling agent in an effective amount to impart ...


68

69
Robert F Reder, Paul D Goldenheim, Robert F Kaiko: Method of providing sustained analgesia with buprenorphine. PURDUE PHARMA, Jones Day, May 9, 2017: US09642850

A method of effectively treating pain in humans is achieved by administering buprenorphine in accordance with first order kinetics over an initial three-day dosing interval, such that a maximum plasma concentration from about 20 pg/ml to about 1052 pg/ml is attained, and thereafter maintaining the a ...


70
Tarik Soliman, Laura M Hales, Daniel B Hall, Christopher So, Howard P Sard, Vishnumurthy Hegde: Therapeutic vitamin D conjugates. Extend Biosciences, Kaplan IP Law P C, Jonathan M Kaplan, March 7, 2017: US09585934

The invention provides non-hormonal vitamin D conjugated to apelin proteins that result in increased absorption, bioavailability or circulating half-life when compared to non-conjugated forms. In some embodiments, the vitamin D targeting groups are coupled to the apelin proteins via the third carbon ...